インドのインスリンポンプ市場の評価：タイプ別、製品別、アクセサリ別、適応症別、年齢層別、エンドユーザー別、流通チャネル別、地域別、機会、予測（2017年度～2031年度）

インドのインスリンポンプの市場規模は、2023年度に3,180万米ドルであり、2031年度までに6,063万米ドルに達すると予測され、2024年度～2031年度の予測期間にCAGRで8.4%の成長が見込まれます。市場は、糖尿病の有病率の上昇、利便性と使いやすさを優先したインスリンデリバリーデバイスへの需要の増加、技術の進歩、政府の取り組み、老年人口の増加、医療費の増加などの要因によって牽引されています。

インドのインスリンポンプ市場は、医療分野で中心的な地位を占めており、大幅な拡大と進化が見込まれています。糖尿病の有病率が上昇を続ける中、先進の糖尿病管理ソリューションの必要性はより深刻になっています。このような状況において、インドのインスリンポンプ市場は技術革新のパイオニアとしての地位を確立しており、血糖調節のより優れた方法を求めて複雑な糖尿病管理を行う人々に希望を与えています。これらの機器は、最小限の労力で正確なインスリン投与ができるという明確な利点があり、糖尿病管理の領域においてかけがえのない資産となっています。

糖尿病の負担を軽減し、医療費を削減するための政府の取り組みが、インドのインスリンポンプ市場の拡大を後押ししています。先進の糖尿病管理技術の採用を提唱する公衆衛生の取り組みや政策により、インスリンポンプへのアクセスや入手性が向上し、インド国民の幅広い層が恩恵を受けています。さらに、インドの人口動態が高齢化していることも、インスリンポンプ市場の拡大の主な要因となっています。糖尿病になりやすい老年人口は、効率的なインスリン管理ソリューションを必要としています。このような背景から、インドのインスリンポンプ市場は、糖尿病コントロールの向上、ひいては生活の質の向上を目指す人々にとっての、革新的で利用しやすい選択肢を提示する楽観性の源として浮上しています。

意識の高まりが市場成長を促進

インドにおけるインスリンポンプの認知度の急増は、市場に好影響を及ぼしています。糖尿病患者は、血糖管理の強化や低血糖症リスクの低減など、インスリンポンプの利点を認識するようになっています。こうした意識の高まりがインスリンポンプの需要を促進し、市場の拡大を促しています。さらに、Indian Diabetes Associationのような組織は、インスリンポンプに関する認知度を高め、関連する誤解を払拭し、糖尿病患者にとっての入手性とアクセシビリティの向上に努める上で重要な役割を果たしています。インスリンポンプに対する認知度が高まるにつれ、これらの機器のインド市場は拡大し、インスリンポンプの開発企業やメーカーに機会がもたらされると予測されます。

インドの老年人口の増加

インドのインスリンポンプ市場は、人口動態の高齢化によって大きく変革しています。老年人口が急速に拡大しているインドでは、この年齢層における糖尿病、特に2型糖尿病の罹患率が著しく増加しています。その結果、効果的な糖尿病管理に向けた極めて重要な手段として、インスリンポンプに対する需要が大幅に増加しています。老年人口の糖尿病に対する脆弱性は、正確なインスリンのコントロールの必要性を強調しています。このような人口動態の変化は、特にインドの糖尿病治療において、医療情勢を大きく変えつつあります。老年人口は糖尿病発症のリスクが高いです。これは、身体活動の低下や肥満の増加などの要因によるものです。糖尿病の有病率の増加は、インスリンポンプに対する需要の増加につながっています。

政府の取り組み

政府の施策は、インドのインスリンポンプ市場を形成する上で重要な役割を果たしています。インド政府は、特に経済的に困難な人々にとっての、インスリンポンプや糖尿病管理技術へのアクセスを向上させるため、さまざまな政策、プログラム、補助金を導入しています。

その一例として、2023年5月、州政府は1型糖尿病患者にインスリンポンプを無料で提供する意向を表明しました。インスリンポンプには多額の費用がかかるため、経済的に困難な状況にある患者には購入不可能です。結果として、ポンプがない場合、これらの患者は毎日のインスリン注射に頼ることになり、腎臓などの重要な臓器に影響を及ぼす深刻な感染症にかかりやすくなります。

当レポートでは、インドのインスリンポンプ市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 インドのインスリンポンプ市場に対するCOVID-19の影響

第4章 エグゼクティブサマリー

第5章 インドのインスリンポンプ市場の見通し（2017年度～2031年度）

• 市場規模と予測
  • 金額
  • 数量
• タイプ別
  • スタンドアロンインスリンポンプ
  • センサー内蔵型インスリンポンプ
• 製品別
  • ポンプ
  • 消耗品
• アクセサリ別
  • インスリンリザーバー、カートリッジ
  • インスリンセット挿入器具
  • バッテリー
• 適応症別
  • 1型糖尿病
  • 2型糖尿病
• 年齢別
  • 成人
  • 小児
  • 両用
• エンドユーザー別
  • 病院
  • 診療所
  • 家庭
  • 研究所
• 流通チャネル別
  • 小売店
  • 病院薬局
  • eコマース
• 地域別
  • 北部
  • 南部
  • 東部
  • 西部、中央部
• 市場シェア：企業別（2023年度）

第6章 市場マッピング（2023年度）

• タイプ別
• 製品別
• アクセサリ別
• 適応症別
• 年齢別
• エンドユーザー別
• 流通チャネル別
• 地域別

第7章 マクロ環境と産業構造

• 需給分析
• 輸入輸出分析
• バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第8章 市場力学

• 成長促進要因
• 成長抑制要因（課題、抑制要因）

第9章 規制枠組みとイノベーション

• 臨床試験
• 特許情勢
• 規制当局の承認
• イノベーション/新技術

第10章 主要企業の情勢

• マーケットリーダー上位5社の競合マトリクス
• マーケットリーダー上位5社の市場収益分析（2023年度）
• 合併と買収/合弁事業（該当する場合）
• SWOT分析（市場企業5社）
• 特許分析（該当する場合）

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

• India Medtronic Pvt. Ltd.
• Agva Healthcare Pvt. Ltd.
• Ypsomed India Pvt. Ltd.
• Tandem Diabetes Care, Inc.

第14章 戦略的推奨

第15章 当社について、免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India Insulin Pumps Market, By Value, In USD Billion, FY2017-FY2031F
• Figure 2. India Insulin Pumps Market, By Volume, In Units, FY2017-FY2031F
• Figure 3. India Insulin Pumps Market Share (%), By Type, FY2017-FY2031F
• Figure 4. India Insulin Pumps Market Share (%), By Product, FY2017-FY2031F
• Figure 5. India Insulin Pumps Market Share (%), By Accessories, FY2017-FY2031F
• Figure 6. India Insulin Pumps Market Share (%), By Disease Indication, FY2017-FY2031F
• Figure 7. India Insulin Pumps Market Share (%), By Age Group, FY2017-FY2031F
• Figure 8. India Insulin Pumps Market Share (%), By End-user, FY2017-FY2031F
• Figure 9. India Insulin Pumps Market Share (%), By Distribution Channel, FY2017-FY2031F
• Figure 10. India Insulin Pumps Market Share (%), By Region, FY2017-FY2031F
• Figure 11. By Type Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 12. By Product Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 13. By Accessories Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 14. By Disease Indication Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 15. By Age Group Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 16. By End-user Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 17. By Distribution Channel Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 18. By Region Map-Market Size (USD Billion) & Growth Rate (%), FY2023

India insulin pumps market size was valued at USD 31.8 million in FY2023, which is expected to reach USD 60.63 million in FY2031, with a CAGR of 8.4% for the forecast period between FY2024 and FY2031. India insulin pumps market is being driven by factors including the rising prevalence of diabetes, increasing demand for insulin delivery devices that prioritize convenience and user-friendliness, technological advancements, government initiatives, growing elderly population, and increasing healthcare expenditure.

India insulin pumps market holds a central position in the healthcare arena and is poised for significant expansion and evolution. As prevalence of diabetes continue to rise, the need for advanced diabetes management solutions becomes more serious. In this context, the insulin pumps market in India stands as a pioneer of innovation, providing hope for individuals navigating the complexities of diabetes management for seeking enhanced methods of blood glucose regulation. These devices offer the distinct advantage of delivering precise insulin doses with minimal effort, rendering them invaluable assets in the realm of diabetes management.

Government efforts to alleviate the diabetes burden and reduce healthcare expenses are driving the expansion of India insulin pumps market. Public health initiatives and policies advocating the adoption of advanced diabetes management technologies have improved insulin pump accessibility and affordability, benefiting a wider cross-section of the Indian populace. Moreover, India's aging demographics is a key factor in the growing insulin pumps market. The elderly population, prone to diabetes, requires efficient insulin management solutions. In this context, the India insulin pumps market emerges as a source of optimism, presenting innovative and accessible choices for individuals striving to achieve improved diabetes control and ultimately enhancing their quality of life.

Heightened Awareness is Propelling Market Growth

The surging awareness of insulin pumps in India is exerting a favourable influence on the India insulin pumps market. Individuals with diabetes increasingly recognize the advantages of insulin pumps, including enhanced blood sugar management and reduced hypoglycaemia risk. This heightened awareness is driving the demand for insulin pumps, fostering market expansion. Additionally, organizations such as the Indian Diabetes Association are playing a crucial role in rising awareness about insulin pumps, dispelling associated misconceptions, and striving to enhance affordability and accessibility for individuals with diabetes. As awareness of insulin pumps continues to rise, the Indian market for these devices is anticipated to expand, creating opportunities for insulin pump developers and manufacturers.

Increasing India's Ageing Population

India insulin pumps market is experiencing a notable transformation driven by the country's aging demographics. With a swiftly expanding elderly population, India is encountering a remarkable increase in the incidence of diabetes, notably Type 2 diabetes, within this age cohort. Consequently, there has been a substantial rise in the demand for insulin pumps as a pivotal instrument for effective diabetes management. The elderly demographic's inherent vulnerability to diabetes underscores the vital necessity for precise insulin control. This demographic shift is reshaping the healthcare landscape, particularly in the context of diabetes care in India. The ageing population is at a higher risk of developing diabetes. It is due to several factors, including the decline in physical activity and the increase in obesity. The increasing prevalence of diabetes is leading to an increased demand for insulin pumps.

Government Initiatives

Government actions are instrumental in shaping the India insulin pumps market. The Indian government has introduced a range of policies, programs, and subsidies to enhance access to insulin pumps and diabetes management technologies, especially for economically challenged individuals. This essay delves into the diverse facets in India, encompassing aspects, like accessibility, affordability, and the advancement of diabetes care technology, driven by the recognition of the growing diabetes burden.

As an example, in May 2023, the state government declared its intention to furnish complimentary insulin pumps to individuals with Type-1 diabetes. Given the substantial expense associated with insulin pumps, those hailing from economically challenged backgrounds find them financially inaccessible. Consequently, in the absence of these pumps, these patients resort to daily insulin injections, which elevates their susceptibility to severe infections affecting vital organs, such as the kidneys.

Rising Demand for Integrated Insulin Pumps

The India insulin pumps market is undergoing a significant evolution due to the introduction of integrated insulin pumps. This revolutionary technology merges insulin administration with continuous glucose monitoring (CGM), promising to revolutionize diabetes management. Integrated systems have the potential to redefine the way diabetes is controlled by offering real-time glucose data and automated insulin delivery, creating a seamless and highly precise method for managing blood sugar levels. The integrated insulin pumps are experiencing heightened demand owing to their capacity to improve blood sugar regulation and lower the risk of hypoglycaemia. As competition intensifies within the market, it is anticipated that the prices of integrated insulin pumps will decrease. The cost reduction will enhance affordability, making these devices more accessible to individuals managing diabetes.

Increasing Need for Insulin Pumps in Type 1 Diabetes

The rising need for solutions in Type 1 Diabetes has substantially led to the growth of India insulin pumps market. The demand for insulin pumps to manage Type 1 diabetes has witnessed a remarkable upswing, reflecting a pivotal shift in the realm of diabetes care. As Type 1 diabetes, an autoimmune condition characterized by insufficient insulin production, continues to affect millions worldwide, the need for advanced solutions to streamline insulin delivery and enhance glycaemic control has surged. For individuals, particularly youngsters, managing Type 1 diabetes, insulin pumps present a viable alternative. These devices can provide a consistent insulin supply, offering a reliable solution for those who may find it challenging to adhere to a strict schedule for insulin injections.

As an illustration, in March 2023, Medtronic unveiled the introduction of the MiniMed 780G system in the Indian market. This system, designed for individuals aged 7 to 80 years with type 1 diabetes, operates as a closed-loop insulin pump system. It harnesses Medtronic's SmartGuard technology to automate the administration of both basal insulin and correction boluses at five-minute intervals. This innovative approach assists individuals with diabetes in navigating their blood sugar levels with increased convenience, minimizing the occurrence of high and low glucose levels.

Impact of COVID-19

The COVID-19 pandemic had a twofold effect on the India insulin pumps market. It has negatively impacted the market due to disruptions in supply chains, limited access to healthcare facilities, and led to economic uncertainties. Import restrictions have resulted in shortages of insulin pumps and diabetes care products, hampering patient access to these devices. Additionally, reduced access to healthcare facilities has posed challenges for diabetes patients in receiving necessary care, including insulin pump therapy. Certain insurance providers have scaled back or entirely removed their coverage for insulin pumps, rendering them less accessible for individuals managing diabetes. However, the pandemic has increased awareness of managing chronic conditions like diabetes, potentially driving demand for insulin pumps. To ensure patient access to essential care and devices, market stakeholders must adapt to the evolving pandemic conditions.

Key Players Landscape and Outlook

The insulin pumps market in India is currently undergoing a significant shift with the rise of new entrants who are redefining the competitive terrain. Historically dominated by well-established healthcare companies, this market is now embracing innovative newcomers who bring fresh insights and state-of-the-art solutions. These emerging players are infusing dynamism into the industry by introducing novel technologies, promoting robust competition, and, most crucially, broadening the reach and affordability of insulin pumps to a wider cross-section of the Indian population.

In the realm of insulin pumps, Indian startups are leading the charge in innovation, reshaping the diabetes management landscape. Amid the growing prevalence of diabetes, these entrepreneurial ventures are leveraging their creativity to craft inventive solutions tailored to the specific requirements of diabetes management in India. For instance, in May 2023, Open MedLabs, an Indian startup, revealed its work on "InsuFlo," an open-loop insulin pump designed to be cost-effective for type-1 diabetic patients in resource-limited settings. The device has reached the prototype phase, demonstrating clinically precise insulin delivery. An upcoming animal study is planned. Ongoing efforts aim to elevate the device's Technology Readiness Level (TRL) and minimize its size to match competitors.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of Covid-19 on India Insulin Pumps Market

4. Executive Summary

5. India Insulin Pumps Market Outlook, FY2017-FY2031

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
  • 5.1.2. By Volume
• 5.2. By Type
  • 5.2.1. Standalone Insulin Pumps
  • 5.2.2. Sensor Integrated Insulin Pumps
• 5.3. By Product
  • 5.3.1. Pumps
    • 5.3.1.1. Tethered Pumps
    • 5.3.1.2. Patch Pumps
    • 5.3.1.3. Others
  • 5.3.2. Consumables
• 5.4. By Accessories
  • 5.4.1. Insulin Reservoir or Cartridges
  • 5.4.2. Insulin Set Insertion Devices
  • 5.4.3. Battery
• 5.5. By Disease Indication
  • 5.5.1. Type 1 Diabetes
  • 5.5.2. Type 2 Diabetes
• 5.6. By Age Group
  • 5.6.1 Adult
  • 5.6.2. Paediatrics
  • 5.6.3. Both
• 5.7. By End-user
  • 5.7.1. Hospitals
  • 5.7.2. Clinics
  • 5.7.3. Homeware
  • 5.7.4. Laboratories
• 5.8. By Distribution Channel
  • 5.6.1 Retail Stores
  • 5.6.2 Hospital Pharmacy
  • 5.6.3 E-commerce
• 5.9. By Region
  • 5.9.1. North
  • 5.9.2. South
  • 5.9.3. East
  • 5.9.4. West and Central
• 5.10. By Company Market Share (%), FY2023

6. Market Mapping, FY2023

• 6.1. By Type
• 6.2. By Product
• 6.3. By Accessories
• 6.4. By Disease Indication
• 6.5. By Age Group
• 6.6. By End-user
• 6.7. By Distribution Channel
• 6.8. By Region

7. Macro Environment and Industry Structure

• 7.1. Supply Demand Analysis
• 7.2. Import Export Analysis
• 7.3. Value Chain Analysis
• 7.4. PESTEL Analysis
  • 7.4.1. Political Factors
  • 7.4.2. Economic System
  • 7.4.3. Social Implications
  • 7.4.4. Technological Advancements
  • 7.4.5. Environmental Impacts
  • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5. Porter's Five Forces Analysis
  • 7.5.1. Supplier Power
  • 7.5.2. Buyer Power
  • 7.5.3. Substitution Threat
  • 7.5.4. Threat from New Entrant
  • 7.5.5. Competitive Rivalry

8. Market Dynamics

• 8.1. Growth Drivers
• 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

• 10.1 Clinical Trials
• 10.2 Patent Landscape
• 10.3 Regulatory Approvals
• 10.4 Innovations/Emerging Technologies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, FY2023)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)
• 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

• 13.1. India Medtronic Pvt. Ltd.
  • 13.1.1. Company Details
  • 13.1.2. Key Management Personnel
  • 13.1.3. Products & Services
  • 13.1.4. Financials (As reported)
  • 13.1.5. Key Market Focus & Geographical Presence
  • 13.1.6. Recent Developments
• 13.2. Agva Healthcare Pvt. Ltd.
• 13.3. Ypsomed India Pvt. Ltd.
• 13.4. Tandem Diabetes Care, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer